<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table 2</label>
 <caption>
  <p>Characterization of HCV and calpain/cathepsin protease inhibitors against SARS-CoV-2 M
   <sup>pro</sup> using a consortium of secondary assays
   <sup>a</sup>.
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <tbody>
   <tr>
    <td colspan="2">
     <inline-graphic xlink:href="41422_2020_356_Tab3_HTML.gif" id="d30e920" xmlns:xlink="http://www.w3.org/1999/xlink"/>
    </td>
   </tr>
   <tr>
    <td colspan="2">
     <inline-graphic xlink:href="41422_2020_356_Tab4_HTML.gif" id="d30e925" xmlns:xlink="http://www.w3.org/1999/xlink"/>
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <sup>a</sup>Value = means ± SE from three independent experiments.
  </p>
  <p>
   <sup>b</sup>N.T. = not tested.
  </p>
  <p>
   <sup>c</sup>The IC
   <sub>50</sub> of PSI (
   <bold>64</bold>) on SARS CoV-2 M
   <sup>pro</sup> was calculated by end point reading of 1 h digestion, instead of the initial velocity.
  </p>
 </table-wrap-foot>
</table-wrap>
